- Home
- KRYS vs UGI Comparison
KRYS vs UGI Comparison
Compare KRYS & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRYS | UGI |
|---|---|---|
| Founded | 2015 | 1940 |
| Country | United States | United States |
| Employees | N/A | 9400 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.8B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | KRYS | UGI |
|---|---|---|
| Price | $299.97 | $35.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $297.60 | $44.00 |
| AVG Volume (30 Days) | 278.4K | ★ 1.9M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.99% |
| EPS Growth | ★ 128.00 | N/A |
| EPS | ★ 1.83 | N/A |
| Revenue | ★ $389,130,000.00 | N/A |
| Revenue This Year | $38.74 | $8.88 |
| Revenue Next Year | $32.53 | $2.27 |
| P/E Ratio | $160.11 | ★ $14.04 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $123.03 | $31.62 |
| 52 Week High | $319.48 | $41.34 |
Technical Indicators
Market Signals| Indicator | KRYS | UGI |
|---|---|---|
| Relative Strength Index (RSI) | 58.30 | 49.54 |
| Support Level | $246.17 | $34.17 |
| Resistance Level | N/A | $37.43 |
| Average True Range (ATR) | 13.41 | 0.96 |
| MACD | -0.35 | 0.15 |
| Stochastic Oscillator | 71.16 | 78.84 |
Price Performance
Historical ComparisonAbout KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.